Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ARG1 | P05089 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16117442 | 0.85 | ALDH1A1 (0.34) | PKML3MBTL1ARG1ALDH1A1HSD11B1 | |
| SCHEMBL16510259 | 0.85 | ALDH1A1 (0.34) | PKML3MBTL1ARG1ALDH1A1HSD11B1 | |
| SCHEMBL21722518 | 0.80 | IDH1 (0.35) | PKML3MBTL1ARG1ALDH1A1HSD11B1 | |
| SCHEMBL26063144 | 0.78 | — | — | |
| SCHEMBL26063090 | 0.78 | — | — | |
| SCHEMBL11892793 | 0.76 | CYP1A2 (0.39) | PKML3MBTL1ALDH1A1HSD11B1CYP1A2 | |
| SCHEMBL1374984 | 0.76 | CYP1A2 (0.34) | PKML3MBTL1ARG1ALDH1A1HSD11B1 | |
| SCHEMBL10139163 | 0.73 | PKM (0.30) | PKML3MBTL1 | |
| SCHEMBL11015180 | 0.72 | ALDH1A1 (0.36) | PKML3MBTL1ARG1ALDH1A1HSD11B1 | |
| Methane SCHEMBL16794470 | 0.70 | APLNR (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230205083-A1 | SALT COMPOUND, RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-06-29 | — | — | US | disclosed |
| US-20200159115-A1 | NOVEL SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230205083-A1 | SALT COMPOUND, RESIST COMPOSITION AND PATTERNING PROCESS | SLC6A9, SLC6A5, REN | PKM 4304/4885L3MBTL1 2742/4885ARG1 3494/4885 |
| US-20200159115-A1 | NOVEL SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION, AND PATTERNING PROCESS | ETV6, EEF2, EEF1G | PKM 2514/4885L3MBTL1 1873/4885ARG1 4500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.